AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca lands three major wins at Healthcare Asia Medtech Awards 2024
It won the Hospital Partnership of the Year - Singapore, Patient Advocacy Program of the Year - Singapore, and the Sustainability Initiative of the Year - Singapore titles.
AstraZeneca lands three major wins at Healthcare Asia Medtech Awards 2024
It won the Hospital Partnership of the Year - Singapore, Patient Advocacy Program of the Year - Singapore, and the Sustainability Initiative of the Year - Singapore titles.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Most Read
1. NUH to establish health centre for early cancer detection in 2025 2. KPMG's Guillaume Sachet on navigating healthcare’s evolution: Cross-border collaboration crucial to fostering trusted AI, innovation 3. Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia 4. 3 in 5 novice nurses struggle with higher-complexity procedures 5. EGH Campus in Bedok North to offer services before 2030 completionResource Center
Read Here
Advertise
Sign Up
Event News
Event News
Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi
![Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi]()
Co-Written / Partner
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
